WR Hambrecht

Portfolio

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is WR Hambrecht's primary investment focus based on its portfolio?

WR Hambrecht's investment activity, according to startupim data, is concentrated in the Health Tech & Life Sciences sector, with its sole recorded portfolio company, Firefly Neuroscience, operating in this area.

When did WR Hambrecht make its first recorded investment?

WR Hambrecht's first recorded investment was in November 2015.

Which company is a notable portfolio company for WR Hambrecht?

Firefly Neuroscience is a notable portfolio company for WR Hambrecht, in which it invested $28,000,000 in November 2015 during a C Round.

Has WR Hambrecht acted as a lead investor in any of its recorded funding rounds?

No, WR Hambrecht has not acted as a lead investor in its recorded funding rounds, specifically in the $28,000,000 C Round for Firefly Neuroscience in November 2015.

What is the investment range for WR Hambrecht?

WR Hambrecht's investment range is $28M - $28M, based on its single recorded investment.

Has WR Hambrecht had any exits from its portfolio companies?

Yes, WR Hambrecht had an exit in November 2021 when its portfolio company, Firefly Neuroscience, went public on NASDAQ.

In which funding stage does WR Hambrecht typically invest?

WR Hambrecht's single recorded investment was in a C Round for Firefly Neuroscience.

What was the amount of WR Hambrecht's investment in Firefly Neuroscience?

WR Hambrecht invested $28,000,000 in Firefly Neuroscience in November 2015.